Citigroup
ARMP icon

Citigroup’s Armata Pharmaceuticals ARMP Stock Holding History

Citigroup’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.8K Buy
+5,160
New +$43.4K ﹤0.01% 4506
2019
Q2 		– Sell
-1
Closed – – 7730
2019
Q1 		$0 Hold
1
– – ﹤0.01% 7646
2018
Q4 		$0 Hold
1
– – ﹤0.01% 7656
2018
Q3 		$0 Hold
1
– – ﹤0.01% 7734
2018
Q2 		$0 Hold
1
– – ﹤0.01% 7594
2018
Q1 		$0 Hold
1
– – ﹤0.01% 7525
2017
Q4 		$0 Hold
1
– – ﹤0.01% 7545
2017
Q3 		$0 Buy
+1
New +$13 ﹤0.01% 7244
2015
Q4 		– Sell
-11
Closed -$6K – 7529
2015
Q3 		$6K Buy
+11
New +$10.1K ﹤0.01% 6634

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup's ARMP Position: Q1 2026 in Review

Citigroup opened a new position in Armata Pharmaceuticals (ARMP) in Q1 2026: 5,160 shares worth $52.8K. The stake represents ﹤0.01% of the portfolio and ranks #4506 among its holdings. This is a return to the name: Citigroup previously reported a position in ARMP as recently as Q1 2019.

Citigroup first reported a position in ARMP in Q3 2015 and has held it in 9 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • Citigroup held 5,160 shares of Armata Pharmaceuticals worth $52.8K as of Q1 2026.
  • Armata Pharmaceuticals was a new Citigroup position in Q1 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4506 holding.
  • Citigroup first reported a position in Armata Pharmaceuticals in Q3 2015 and has held it in 9 quarters since.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.